FARALLON CAPITAL MANAGEMENT LLC - Q1 2017 holdings

$9.11 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 72 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 84.0% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$947,675,000
+135.0%
4,020,000
+122.8%
10.40%
+123.9%
TWX BuyTIME WARNER INC$552,550,000
+173.2%
5,655,000
+169.9%
6.06%
+160.3%
NXPI BuyNXP SEMICONDUCTORS N V$507,668,000
+62.6%
4,905,000
+54.0%
5.57%
+54.9%
YHOO BuyYAHOO INC$462,940,000
+932.0%
9,975,000
+759.9%
5.08%
+882.4%
FB NewFACEBOOK INCcl a$366,921,0002,583,043
+100.0%
4.03%
Q BuyQUINTILES IMS HOLDINGS INC$344,951,000
+24.8%
4,283,508
+17.8%
3.78%
+18.9%
BEAV BuyB/E AEROSPACE INC$322,473,000
+31.2%
5,030,000
+23.1%
3.54%
+25.0%
MJN BuyMEAD JOHNSON NUTRITION CO$318,684,000
+138.5%
3,577,500
+89.4%
3.50%
+127.2%
PLYA NewPLAYA HOTELS & RESORTS NV$316,771,00030,168,680
+100.0%
3.48%
V BuyVISA INC$260,143,000
+26.1%
2,927,228
+10.7%
2.85%
+20.1%
WAB NewWABTEC CORP$246,228,0003,156,764
+100.0%
2.70%
DVMT BuyDELL TECHNOLOGIES INC$237,829,000
+25.4%
3,711,440
+7.5%
2.61%
+19.4%
HDS BuyHD SUPPLY HLDGS INC$217,946,000
+10.4%
5,299,594
+14.1%
2.39%
+5.1%
WWAV BuyWHITEWAVE FOODS CO$205,402,000
+2.2%
3,658,102
+1.2%
2.25%
-2.6%
CMCSA BuyCOMCAST CORP NEWcl a$179,317,000
+2.8%
4,770,325
+88.8%
1.97%
-2.1%
SBAC NewSBA COMMUNICATIONS CORP NEWcl a$154,972,0001,287,463
+100.0%
1.70%
LLY BuyLILLY ELI & CO$134,366,000
+576.6%
1,597,500
+491.7%
1.47%
+543.7%
BuySOLARCITY CORPnote 1.625%11/0$128,012,000
+11.2%
143,097,000
+5.5%
1.40%
+5.9%
FIS BuyFIDELITY NATL INFORMATION SV$123,597,000
+8.6%
1,552,339
+3.2%
1.36%
+3.4%
RDUS BuyRADIUS HEALTH INC$120,472,000
+48.7%
3,117,000
+46.3%
1.32%
+41.7%
LBTYK NewLIBERTY GLOBAL PLC$113,849,0003,249,122
+100.0%
1.25%
LBTYA NewLIBERTY GLOBAL PLC$112,904,0003,147,585
+100.0%
1.24%
MBBYF NewMOBILEYE N V AMSTELVEEN$111,134,0001,810,000
+100.0%
1.22%
ALR BuyALERE INC$108,483,000
+24.0%
2,730,500
+21.6%
1.19%
+18.2%
VEON NewVEON LTDsponsored adr$42,572,00010,434,422
+100.0%
0.47%
LOGM NewLOGMEIN INC$39,506,000405,185
+100.0%
0.43%
AZN BuyASTRAZENECA PLCsponsored adr$35,889,000
+259.9%
1,152,500
+215.8%
0.39%
+242.6%
HZNP BuyHORIZON PHARMA PLC$35,398,000
+258.6%
2,395,000
+292.6%
0.39%
+240.4%
SWC NewSTILLWATER MNG CO$31,283,0001,811,382
+100.0%
0.34%
HW NewHEADWATERS INC$30,641,0001,305,000
+100.0%
0.34%
VAL NewVALSPAR CORP$30,509,000275,000
+100.0%
0.34%
GWPH BuyGW PHARMACEUTICALS PLCads$30,235,000
+82.9%
250,000
+69.0%
0.33%
+74.7%
IMMU NewIMMUNOMEDICS INC$26,883,0004,155,000
+100.0%
0.30%
BMY BuyBRISTOL MYERS SQUIBB CO$24,063,000
+32.8%
442,500
+42.7%
0.26%
+26.3%
PBYI NewPUMA BIOTECHNOLOGY INC$21,595,000580,500
+100.0%
0.24%
AKAOQ BuyACHAOGEN INC$20,626,000
+352.6%
817,500
+133.6%
0.23%
+334.6%
RYAAY NewRYANAIR HLDGS PLCsponsored adr ne$15,245,000183,715
+100.0%
0.17%
PTLA BuyPORTOLA PHARMACEUTICALS INC$15,088,000
+572.4%
385,000
+285.0%
0.17%
+538.5%
GLPG BuyGALAPAGOS NVspon adr$10,343,000
+77.2%
120,000
+31.9%
0.11%
+68.7%
STML BuySTEMLINE THERAPEUTICS INC$9,982,000
+262.3%
1,167,500
+353.4%
0.11%
+243.8%
LJPC NewLA JOLLA PHARMACEUTICAL CO$7,686,000257,500
+100.0%
0.08%
CLVS NewCLOVIS ONCOLOGY INC$5,094,00080,000
+100.0%
0.06%
KATE NewKATE SPADE & CO$4,878,000210,000
+100.0%
0.05%
ALR NewALERE INCcall$3,258,00082,000
+100.0%
0.04%
ACRS NewACLARIS THERAPEUTICS INC$3,188,000106,894
+100.0%
0.04%
NewGNC HLDGS INCnote 1.500% 8/1$2,133,0003,500,000
+100.0%
0.02%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14
13F-HR/A2024-02-12
SC 13G/A2024-02-01
SC 13G/A2024-01-23

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export FARALLON CAPITAL MANAGEMENT LLC's holdings